PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsJiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
BortezomibBortezomib2022-07-262032-2042
Multiple myeloma
,
Mantle-cell lymphoma
DecitabineDecitabine2022-04-152028-2030
Myelodysplastic syndromes
,
Myeloid leukemia
FulvestrantFulvestrant2022-02-102034
Breast neoplasms
GemcitabineGemcitabine2013-05-072033
Breast neoplasms,
Ovarian neoplasms,
Pancreatic ductal carcinoma,
Non-small-cell lung carcinoma
IcatibantIcatibant2020-03-09
Hereditary angioedemas
MicafunginMicafungin2021-07-09
Candidemia,
Mycoses,
Candidiasis
OlanzapineOlanzapine2018-09-242025-2041
Schizophrenia,
Psychotic disorders,
Bipolar disorder,
Schizophrenia spectrum and other psychotic disorders,
Bulimia,
Panic disorder,
Major depressive disorder,
Obsessive-compulsive disorder
PemetrexedPemetrexed2022-05-252035
Non-small-cell lung carcinoma,
Mesothelioma,
Mesothelial neoplasms
VinorelbineVinorelbine2012-09-26
Breast neoplasms,
Ovarian neoplasms,
Non-small-cell lung carcinoma,
Hodgkin disease
AzacitidineAzacitidine2023-06-282029-2030
Myelodysplastic syndromes,
Myeloid leukemia acute,
Myelomonocytic leukemia chronic,
Sideroblastic anemia,
Refractory anemia
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use